Breaking

Trump announces newest nominations to lead DOJ, regulate US railroads
Trump nominates TV producer, creator of ‘The Apprentice,’ to serve in new administration
Lawmakers react to stopgap funding and averting government shutdown
Trump nominates pair to help lead DOJ, announces Federal Railroad Administration pick
DAVID MARCUS: De facto President Trump’s handling of shutdown threat was a masterclass
30 people die in a crash between a passenger bus and a truck in Brazil
New report warns of growing national security threat to U.S. as China builds AI: ‘Significant and concerning’
What we know about the suspect behind the German Christmas market attack

Politics
Business
World
Investing
Search for:

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Top 5 Canadian Mining Stocks This Week: Omineca Jumps 67 Percent

December 21, 2024

Opawica Announces the Closing of Non-Brokered Private Placement

December 21, 2024

Silver Price Forecast: Top Trends That Will Affect Silver in 2025

December 20, 2024

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,342)
- Investing (3,471)
- Politics (5,157)
- World (4,636)

Disclaimer: yourwalletinside.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2024 yourwalletinside.com | All Rights Reserved

Top

Politics
Business
World
Investing

Type above and press Enter to search. Press Esc to cancel.